Identification of Chemical Constituents and Blood-absorbed Components of Shenqi Fuzheng Extract Based on UPLC-Triple-TOF/MS Technology

Menglei Wang , Bingjie Zhu , Meng Gao , Yining Hu , Xiang Li , Liangfeng Liu , Zhiwei Ge , Wenhua Huang , Jie Liao , Xiaohui Fan

›› 2024, Vol. 3 ›› Issue (4) : 222 -238.

PDF
›› 2024, Vol. 3 ›› Issue (4) :222 -238. DOI: 10.14218/FIM.2024.00037
Original Article
research-article
Identification of Chemical Constituents and Blood-absorbed Components of Shenqi Fuzheng Extract Based on UPLC-Triple-TOF/MS Technology
Author information +
History +
PDF

Abstract

Background and objectives Shenqi Fuzheng (SQ) is a widely used Chinese medicine formula known for its immune-enhancing and Qi-supplementing properties. However, the blood-absorbed components of SQ and their pharmacokinetics remain underexplored. This study aimed to comprehensively analyze the chemical constituents of SQ and investigate their absorption and pharmacokinetic behavior in rat plasma.

Methods Ultra-performance liquid chromatography-triple quadrupole time-of-flight mass spectrometry (hereinafter referred to as UPLC-Triple-TOF/MS) is employed to identify the chemical components in SQ extract and quantify the components absorbed into the blood after oral administration in rats. This method provides fragmentation patterns of compounds and key pharmacokinetic profiles of blood-absorbed compounds.

Results A total of 105 compounds are identified from the SQ extract, and 40 are detected in the blood following oral administration. Organic acids and amino acids are found at higher concentrations in the bloodstream. Compounds such as Astragalosides promptly enter the bloodstream within 5 m after administration, with levels declining after 15 m. Flavonoids are absorbed within 15-30 m, and the peak of alkaloids occurs approximately 1 h after administration.

Conclusions This study provides new insights into the chemical composition and pharmacokinetics of SQ, highlighting the dynamic changes in the content of absorbed compounds in the blood. It further promotes the comprehensive characterization of traditional Chinese medicine formulations through UPLC-Triple-TOF/MS. Future research should focus on elucidating the pharmacological activities of the identified compounds and investigating their potential synergistic effects within the formulation.

Keywords

Traditional Chinese medicine / Ultra-performance liquid chromatogra-phy-triple quadrupole time-of-flight mass spectrometry / UPLC-Triple-TOF/MS / Chemical composition / Blood-absorbed components / Chinese medicine compound / Shenqi Fuzheng

Cite this article

Download citation ▾
Menglei Wang, Bingjie Zhu, Meng Gao, Yining Hu, Xiang Li, Liangfeng Liu, Zhiwei Ge, Wenhua Huang, Jie Liao, Xiaohui Fan. Identification of Chemical Constituents and Blood-absorbed Components of Shenqi Fuzheng Extract Based on UPLC-Triple-TOF/MS Technology. , 2024, 3(4): 222-238 DOI:10.14218/FIM.2024.00037

登录浏览全文

4963

注册一个新账户 忘记密码

Acknowledgments

The authors thank the High-Performance Computing Cluster of the Zhejiang University Innovation Center of the Yangtze River Delta for their technical support.

Funding

This work is supported by the National Natural Science Foundation of China (No. 82204772).

Conflict of interest

XHF and JL have been editorial board members of Future Integra-tive Medicine since March 2024. LFL and WHH are employees of Livzon Pharmaceutical Group Inc. This company has no conflicts of interest regarding the publication of this paper. The other au-thors report no conflict of interest in this work.

Author contributions

Research design, material preparation, writing and revision of the manuscript (MLW, MG, YNH, LFL, WHH), data collec-tion (XL, ZWG, BJZ), conceptualization and supervision of the project (JL, XHF). All authors approve the final version of the manuscript.

Ethical statement

This study was carried out in accordance with the recommenda-tions in the Regulations for the Administration of Affairs Concern-ing Experimental Animals and Guidelines for the Ethical Review of Laboratory Animal Welfare. The Animal Care and Use Com-mittee of the Zhejiang University School of Medicine approved the animal experiments (Protocol Number: 22768). All surgery was performed under tribromoethanol, and all efforts were made to minimize suffering.

Data sharing statement

The data used to support the findings of this study are available from the corresponding author upon request.

References

[1]

Huang K, Zhang P, Zhang Z, Youn JY, Wang C, Zhang H, et al. Tradi-tional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms. Pharmacol Ther 2021;225:107843. doi:10.1016/j.pharmthera.2021.107843,PMID:33811957.

[2]

Li S, Wu Z, Le W. Traditional Chinese medicine for dementia. Alz-heimers Dement 2021; 17(6):1066-1071. doi:10.1002/alz.12258,PMID:33682261.

[3]

Efferth T, Li PC, Konkimalla VS, Kaina B. From traditional Chinese med-icine to rational cancer therapy. Trends Mol Med 2007; 13(8):353-361. doi:10.1016/j.molmed.2007.07.001, PMID:17644431.

[4]

Dong J, Su SY, Wang MY, Zhan Z. Shenqi fuzheng, an injection concoct-ed from Chinese medicinal herbs, combined with platinum-based chemotherapy for advanced non-small cell lung cancer: a system-atic review. J Exp Clin Cancer Res 2010; 29(1):137. doi:10.1186/1756-9966-29-137,PMID:20969765.

[5]

Li W, Zhang Z, Berik E, Liu Y, Pei W, Chen S, et al. Energy preserva-tion for skeletal muscles: Shenqi Fuzheng injection prevents tissue wasting and restores bioenergetic profiles in a mouse model of chemotherapy-induced cachexia. Phytomedicine 2024;125:155269. doi:10.1016/j.phymed.2023.155269,PMID:38237510.

[6]

Yang J, Li Y, Chau CI, Shi J, Chen X, Hu H, et al. Efficacy and safety of traditional Chinese medicine for cancer-related fatigue: a sys-tematic literature review of randomized controlled trials. Chin Med 2023; 18(1):142. doi:10.1186/s13020-023-00849-y,PMID:37907925.

[7]

Wang J, Tong X, Li P, Cao H, Su W. Immuno-enhancement effects of Shenqi Fuzheng Injection on cyclophosphamide-induced immuno-suppression in Balb/c mice. J Ethnopharmacol 2012; 139(3):788-795. doi:10.1016/j.jep.2011.12.019,PMID:22212503.

[8]

Liao J, Hao C, Huang W, Shao X, Song Y, Liu L, et al. Network pharma-cology study reveals energy metabolism and apoptosis pathways-me-diated cardioprotective effects of Shenqi Fuzheng. J Ethnopharmacol 2018; 227:155-165. doi:10.1016/j.jep.2018.08.029,PMID:30145173.

[9]

He P, Chen L, Qin X, Du G, Li Z. Astragali Radix-Codonopsis Radix-Jujubae Fructus water extracts ameliorate exercise-induced fatigue in mice via modulating gut microbiota and its metabolites. J Sci Food Agric 2022; 102(12):5141-5152. doi:10.1002/jsfa.11866,PMID:35285935.

[10]

Li T, Baochen Z, Yue Z, Cheng W, Yali W, Zongxi S, et al. Network Phar-macology-Based identification of pharmacological mechanism of SQFZ injection in combination with Docetaxel on lung cancer. Sci Rep 2019; 9(1):4533. doi:10.1038/s41598-019-40954-3,PMID:30872765.

[11]

Du J, Cheng BC, Fu XQ, Su T, Li T, Guo H, et al. In vitro assays sug-gest Shenqi Fuzheng Injection has the potential to alter melanoma immune microenvironment. J Ethnopharmacol 2016; 194:15-19. doi:10.1016/j.jep.2016.08.038,PMID:27566207.

[12]

Li S, Zhu Z, Chen Z, Guo Z, Wang Y, Li X, et al. Network pharmacol-ogy-based investigation of the effects of Shenqi Fuzheng injection on glioma proliferation and migration via the SRC/PI3K/AKT signal-ing pathway. J Ethnopharmacol 2024;328:118128. doi:10.1016/j.jep.2024.118128, PMID:38561056.

[13]

Wang J, Tong X, Li P, Liu M, Peng W, Cao H, et al. Bioactive compo-nents on immuno-enhancement effects in the traditional Chinese medicine Shenqi Fuzheng Injection based on relevance analysis be-tween chemical HPLC fingerprints and in vivo biological effects. J Eth-nopharmacol 2014; 155(1):405-415. doi:10.1016/j.jep.2014.05.038,PMID:24950446.

[14]

Zhu B, Li Z, Jin Z, Zhong Y, Lv T, Ge Z, et al. Knowledge-based in silico fragmentation and annotation of mass spectra for natural products with MassKG. Comput Struct Biotechnol J 2024; 23:3327-3341. doi:10.1016/j.csbj.2024.09.001,PMID:39310281.

[15]

Sui M, Feng S, Liu G, Chen B, Li Z, Shao P. Deep eutectic solvent on extraction of flavonoid glycosides from Dendrobium officinale and rapid identification with UPLC-triple-TOF/MS. Food Chem 2023;401:134054. doi:10.1016/j.foodchem.2022.134054,PMID:36103742.

[16]

Zhao TT, Zhang Y, Zhang CQ, Chang YF, Cui MR, Sun Y, et al. Combined with UPLC-Triple-TOF/MS-based plasma lipidomics and molecular pharmacology reveals the mechanisms of schisandrin against Alzhei-mer’s disease. Chin Med 2023; 18(1):11. doi:10.1186/s13020-023-00714-y,PMID:36747236.

[17]

Chen LH, Zhang YB, Yang XW, Xu W, Wang YP. Characterization and quantification of ginsenosides from the root of Panax quinquefolius L. by integrating untargeted metabolites and targeted analysis us-ing UPLC-Triple TOF-MS coupled with UFLC-ESI-MS/MS. Food Chem 2022;384:132466. doi:10.1016/j.foodchem.2022.132466,PMID:35202989.

[18]

Zuo T, Zhang C, Li W, Wang H, Hu Y, Yang W, et al. Offline two-di-mensional liquid chromatography coupled with ion mobility-quad-rupole time-of-flight mass spectrometry enabling four-dimensional separation and characterization of the multicomponents from white ginseng and red ginseng. J Pharm Anal 2020; 10(6):597-609. doi:10.1016/j.jpha.2019.11.001,PMID:33425454.

[19]

Jia W, Bi Q, Jiang S, Tao J, Liu L, Yue H, et al. Franch.) Nannf. Hypoglycemic activ-ity of Codonopsis pilosula ( in vitro and in vivo and its chemical composition identification by UPLC-Triple-TOF-MS/MS. Food Funct 2022; 13(5):2456-2464. doi:10.1039/d1fo03761g,PMID:35147627.

[20]

Liang C, Yao Y, Ding H, Li X, Li Y, Cai T. Rapid classification and identi-fication of chemical components of Astragali radix by UPLC-Q-TOF-MS. Phytochem Anal 2022; 33(6):943-960. doi:10.1002/pca.3150,PMID:35726352.

[21]

Liu X, Liu J, Fu B, Chen R, Jiang J, Chen H, et al. DCABM-TCM: A Da-tabase of Constituents Absorbed into the Blood and Metabolites of Traditional Chinese Medicine. J Chem Inf Model 2023; 63(15):4948-4959. doi:10.1021/acs.jcim.3c00365,PMID:37486750.

[22]

Chau SL, Huang ZB, Song YG, Yue RQ, Ho A, Lin CZ, et al. Comprehen-sive Quantitative Analysis of SQ Injection Using Multiple Chromato-graphic Technologies. Molecules 2016; 21(8):1092. doi:10.3390/mol-ecules21081092,PMID:27548134.

[23]

Xu W, Zhou F, Zhu Q, Bai M, Luo T, Zhou L, et al. Calycosin-7-O-β-D-glucoside attenuates palmitate-induced lipid accumulation in hepat-ocytes through AMPK activation. Eur J Pharmacol 2022;925:174988. doi:10.1016/j.ejphar.2022.174988,PMID:35490724.

[24]

Su J, Gao C, Xie L, Fan Y, Shen Y, Huang Q, et al. Astragaloside II Ame-liorated Podocyte Injury and Mitochondrial Dysfunction in Strepto-zotocin-Induced Diabetic Rats. Front Pharmacol 2021;12:638422. doi:10.3389/fphar.2021.638422,PMID:33796024.

[25]

Chen Z, Su Y, Ding J, He J, Lai L, Song Y. Lobetyolin protects mice against LPS-induced sepsis by downregulating the production of inflamma-tory cytokines in macrophage. Front Pharmacol 2024;15:1405163. doi:10.3389/fphar.2024.1405163,PMID:38799158.

[26]

Sevimli-Gür C, Onbaşılar I, Atilla P, Genç R, Cakar N, Deliloğlu-Gürhan I, et al. In vitro growth stimulatory and in vivo wound healing studies on cycloartane-type saponins of Astragalus genus. J Ethnopharma-col 2011; 134(3):844-850. doi:10.1016/j.jep.2011.01.030,PMID:21291980.

[27]

Ziyang T, Xirong H, Chongming A, Tingxin L. The potential molecu-lar pathways of Astragaloside-IV in colorectal cancer: A systematic review. Biomed Pharmacother 2023;167:115625. doi:10.1016/j.bi-opha.2023.115625,PMID:37793276.

[28]

Xu F, Cui WQ, Wei Y, Cui J, Qiu J, Hu LL, et al. Astragaloside IV in-hibits lung cancer progression and metastasis by modulating mac-rophage polarization through AMPK signaling. J Exp Clin Cancer Res 2018; 37(1):207. doi:10.1186/s13046-018-0878-0,PMID:30157903.

[29]

Jiang K, Lu Q, Li Q, Ji Y, Chen W, Xue X. Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK sign-aling. Int Immunopharmacol 2017; 42:195-202. doi:10.1016/j.in-timp.2016.10.001,PMID:27930970.

[30]

Fang Gong Y, Hou S, Xu JC, Chen Y, Zhu LL, Xu YY, et al. Amelioratory effects of astragaloside IV on hepatocarcinogenesis via Nrf2-medi-ated pSmad3C/3L transformation. Phytomedicine 2023;117:154903. doi:10.1016/j.phymed.2023.154903,PMID:37301185.

[31]

Wang Y, Zhang Z, Cheng Z, Xie W, Qin H, Sheng J. Astragalo-side in cancer chemoprevention and therapy. Chin Med J (Engl) 2023; 136(10):1144-1154. doi:10.1097/CM9.0000000000002661,PMID:37075760.

[32]

Yang C, Wu C, Xu D, Wang M, Xia Q. AstragalosideII inhibits autophag-ic flux and enhance chemosensitivity of cisplatin in human cancer cells. Biomed Pharmacother 2016; 81:166-175. doi:10.1016/j.bi-opha.2016.03.025,PMID:27261591.

[33]

He W, Tao W, Zhang F, Jie Q, He Y, Zhu W, et al. Lobetyolin induces apoptosis of colon cancer cells by inhibiting glutamine metabolism. J Cell Mol Med 2020; 24(6):3359-3369. doi:10.1111/jcmm.15009,PMID:31990147.

[34]

Chukhchin DG, Bolotova K, Sinelnikov I, Churilov D, Novozhilov E. Exosomes in the phloem and xylem of woody plants. Planta 2019; 251(1):12. doi:10.1007/s00425-019-03315-y,PMID:31776666.

[35]

Mu N, Li J, Zeng L, You J, Li R, Qin A, et al. Plant-Derived Exosome-Like Nanovesicles: Current Progress and Prospects. Int J Nanomedicine 2023; 18:4987-5009. doi:10.2147/IJN.S420748,PMID:37693885.

[36]

Zhao B, Lin H, Jiang X, Li W, Gao Y, Li M, et al. Exosome-like nanoparti-cles derived from fruits, vegetables, and herbs: innovative strategies of therapeutic and drug delivery. Theranostics 2024; 14(12):4598-4621. doi:10.7150/thno.97096,PMID:39239509.

[37]

Cai Q, Halilovic L, Shi T, Chen A, He B, Wu H, et al. Extracellular vesi-cles: cross-organismal RNA trafficking in plants, microbes, and mam-malian cells. Extracell Vesicles Circ Nucl Acids 2023; 4(2):262-282. doi:10.20517/evcna.2023.10,PMID:37575974.

[38]

Simbari F, McCaskill J, Coakley G, Millar M, Maizels RM, Fabriás G, et al. Plasmalogen enrichment in exosomes secreted by a nematode parasite versus those derived from its mouse host: implications for exosome stability and biology. J Extracell Vesicles 2016;5:30741. doi:10.3402/jev.v5.30741,PMID:27389011.

[39]

Rigalli JP, Gagliardi A, Diester K, Bajraktari-Sylejmani G, Blank A, Burhenne J, et al. Extracellular Vesicles as Surrogates for the Regulation of the Drug Transporters ABCC2 (MRP2) and ABCG2 (BCRP). Int J Mol Sci 2024; 25(7):4118. doi:10.3390/ijms25074118,PMID:38612927.

[40]

Chen LH, Zhang YB, Yang XW, Xu J, Wang ZJ, Sun YZ, et al. Application of UPLC-Triple TOF-MS/MS metabolomics strategy to reveal the dynam-ic changes of triterpenoid saponins during the decocting process of Asian ginseng and American ginseng. Food Chem 2023;424:136425. doi:10.1016/j.foodchem.2023.136425,PMID:37263091.

[41]

Guo W, Xu X, Xiao Y, Zhang J, Shen P, Lu X, et al. Salvianolic acid C at-tenuates cerebral ischemic injury through inhibiting neuroinflamma-tion via the TLR4-TREM1-NF-κB pathway. Chin Med 2024; 19(1):46. doi:10.1186/s13020-024-00914-0,PMID:38468280.

[42]

Shi L, Deng J, He J, Zhu F, Jin Y, Zhang X, et al. Integrative transcrip-tomics and proteomics analysis reveal the protection of Astragalo-side IV against myocardial fibrosis by regulating senescence. Eur J Pharmacol 2024;975:176632. doi:10.1016/j.ejphar.2024.176632,PMID:38718959.

[43]

Li X, Mu Y, Hua M, Wang J, Zhang X. Integrated phenotypic, tran-scriptomics and metabolomics: growth status and metabolite ac-cumulation pattern of medicinal materials at different harvest pe-riods of Astragalus Membranaceus Mongholicus. BMC Plant Biol 2024; 24(1):358. doi:10.1186/s12870-024-05030-7,PMID:38698337.

[44]

Zhang J, Zhong D, Hou F, Xie X, Gao J, Peng C. Transcriptomics-based Study on the Mechanism of Heart Failure Amelioration by Water Decoction and Water-soluble Alkaloids of Fuzi. Future Integr Med 2024; 3(2):75-86. doi:10.14218/fim.2024.00005.

PDF

0

Accesses

0

Citation

Detail

Sections
Recommended

/